Exicure grosses $22mm via PIPE
- Antisense, Oligonucleotides
Drug Discovery Tools
- Gene Therapy, Cell Therapy
- Nanotechnology, Chips, etc.
- Topical Delivery
- Drug Delivery
- Private Investment in Public Equity
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.